TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SERA

Sera Prognostics Inc

Healthcare · Medical Devices

2.10$ +2.5% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Sera Prognostics Inc (SERA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.0% of the shares are freely tradable; institutional investors hold 63.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 63.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 11.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 39Mio.

Largest Shareholders

Institutions

Institutions SERA
Name Stake (%) Shares Change (%) Date
Baker Bros Advisors LP 13.94 5,498,170 +0.0 03/31/2026
Whetstone Capital Advisors, LLC 8.38 3,306,889 +0.0 06/30/2026
Aberdeen Group PLC 6.98 2,753,525 +7.9 06/30/2026
Vivo Capital, LLC 4.18 1,650,440 +0.0 06/30/2026
Vanguard Capital Management, LLC 3.05 1,204,115 +0.0 03/31/2026
CapTrust Financial Advisors 1.36 536,761 +0.0 03/31/2026

Funds

Funds SERA
Name Stake (%) Shares Change (%) Date
abrdn Healthcare Investors 3.55 1,400,105 +1.0 07/31/2026
abrdn Healthcare Opportunities 3.52 1,387,426 +2.3 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.25 887,016 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.96 380,212 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings SERA
Person Role Shares Value As of Type
Critchfield Gregory C Director 846,886 1,778,461 $ Jul 10, 2026 direct
Lindgardt Zhenya Chief Executive Officer 837,848 1,759,481 $ Sep 10, 2026 direct
Jackson Benjamin General Counsel 159,566 335,089 $ Sep 10, 2026 direct
Gleason Scott Chief Financial Officer 117,924 247,640 $ Aug 31, 2026 direct
Inglis Tiffany Eul Davis Chief Medical Officer 91,589 192,337 $ Sep 10, 2026 direct
Mirza Mansoor Raza Director 81,937 172,068 $ Jul 10, 2026 direct
Phillips Joshua Director 81,691 171,551 $ Jul 10, 2026 direct
Anderson Dyaarl Lee Jr. Chief Commercial Officer 76,198 160,016 $ Sep 10, 2026 direct
Kamdar Kim P. Director 58,420 122,682 $ Jul 10, 2026 direct
Barlow Jane F Director 47,088 98,885 $ Jul 10, 2026 direct
Capone Mark Christopher Director 44,379 93,196 $ Jul 10, 2026 direct
Lawrence Sandra AJ Director 41,175 86,468 $ Jul 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 10, 2026 Inglis Tiffany Eul Davis Chief Medical Officer Sell 486 2.00 972
Sep 10, 2026 Anderson Dyaarl Lee Jr. Chief Commercial Officer Sell 1,800 2.00 3,600
Sep 10, 2026 Lindgardt Zhenya Chief Executive Officer Sell 7,022 2.00 14,044
Sep 10, 2026 Jackson Benjamin General Counsel Sell 2,190 2.00 4,380
Sep 8, 2026 Lindgardt Zhenya Chief Executive Officer Sell 20,139 2.00 40,278
Aug 31, 2026 Gleason Scott Chief Financial Officer Other 117,924 0.00
Jul 10, 2026 Phillips Joshua Director Other 2,260 0.00
Jul 10, 2026 Phillips Joshua Director Other 22,426 0.00
Jul 10, 2026 Barlow Jane F Director Other 1,949 0.00
Jul 10, 2026 Barlow Jane F Director Other 22,426 0.00
Jul 10, 2026 Mirza Mansoor Raza Director Other 1,771 0.00
Jul 10, 2026 Mirza Mansoor Raza Director Other 22,426 0.00
Jul 10, 2026 Kamdar Kim P. Director Other 3,421 0.00
Jul 10, 2026 Kamdar Kim P. Director Other 22,426 0.00
Jul 10, 2026 Capone Mark Christopher Director Other 1,975 0.00
Jul 10, 2026 Capone Mark Christopher Director Other 42,404 0.00
Jul 10, 2026 Lawrence Sandra AJ Director Other 2,276 0.00
Jul 10, 2026 Lawrence Sandra AJ Director Other 22,426 0.00
Jul 10, 2026 Critchfield Gregory C Director Other 1,594 0.00
Jul 10, 2026 Critchfield Gregory C Director Other 22,426 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?